← Back to directory

Éric Deutsch

Researcher Next ID · RN-032604

Researcher · Medicine

Inserm

Paris, France

Accepting doctoral researchersFunding unknown
Works count
1,208
Citation count
35,113
H-index
77
i10-index
369

Research interests

Medicine
Physics and Astronomy
Cancer Immunotherapy and Biomarkers
Radiomics and Machine Learning in Medical Imaging
Advanced Radiotherapy Techniques
Effects of Radiation Exposure
Lung Cancer Treatments and Mutations

Publications

  • Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome

    Cell · 2024 · https://doi.org/10.1016/j.cell.2024.05.029

  • Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer

    Nature Medicine · 2022 · https://doi.org/10.1038/s41591-021-01655-5

  • Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    Annals of Oncology · 2021 · 10.1016/j.annonc.2021.06.015

  • Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)

    Radiotherapy and Oncology · 2021 · 10.1016/j.radonc.2021.04.021

  • Radiotherapy–immunotherapy combinations – perspectives and challenges

    Molecular Oncology · 2020 · 10.1002/1878-0261.12658

  • AI-driven quantification, staging and outcome prediction of COVID-19 pneumonia

    Medical Image Analysis · 2020 · 10.1016/j.media.2020.101860

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer · 2020 · https://doi.org/10.1136/jitc-2019-000337

  • Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics

    Scientific Reports · 2020 · 10.1038/s41598-020-69298-z

  • CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance

    Cancer Immunology Research · 2019 · 10.1158/2326-6066.cir-18-0633

  • Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy

    The Lancet Oncology · 2019 · 10.1016/s1470-2045(19)30171-8

  • Brachytherapy: An overview for clinicians

    CA A Cancer Journal for Clinicians · 2019 · 10.3322/caac.21578

  • AGuIX ® from bench to bedside—Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine

    British Journal of Radiology · 2018 · 10.1259/bjr.20180365

  • CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages

    European Respiratory Journal · 2018 · 10.1183/13993003.02120-2017

  • A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

    The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30413-3

  • Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology

    Annals of Oncology · 2017 · 10.1093/annonc/mdx034

  • High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

    Cancer Discovery · 2017 · https://doi.org/10.1158/2159-8290.cd-16-1396

  • Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

    Science · 2017 · https://doi.org/10.1126/science.aan3706

  • First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas

    Clinical Cancer Research · 2016 · 10.1158/1078-0432.ccr-16-1297

  • The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy

    British Journal of Radiology · 2014 · 10.1259/bjr.20140134

  • Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

    Cell Death and Differentiation · 2013 · 10.1038/cdd.2013.124

  • Nanoscale Radiotherapy with Hafnium Oxide Nanoparticles

    Future Oncology · 2012 · https://doi.org/10.2217/fon.12.96

  • Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity

    Cancer Research · 2008 · https://doi.org/10.1158/0008-5472.can-08-0757

  • Mechanisms of Disease: signaling of the insulin-like growth factor 1 receptor pathway—therapeutic perspectives in cancer

    Nature Clinical Practice Oncology · 2007 · 10.1038/ncponc0934

  • Tumour stem cell-targeted treatment: elimination or differentiation

    Annals of Oncology · 2006 · 10.1093/annonc/mdl074

  • BCR-ABL down-regulates the DNA repair protein DNA-PKcs

    Blood · 2001 · 10.1182/blood.v97.7.2084

  • Eulerian prediction of the fluid/particle correlated motion in turbulent two-phase flows

    Flow Turbulence and Combustion · 1993 · 10.1007/bf01082549

Current projects

    No projects listed.